As of 2025-07-14, the EV/EBITDA ratio of VBI Vaccines Inc (VBIV) is -0.00. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VBIV's latest enterprise value is 0.01 mil USD. VBIV's TTM EBITDA according to its financial statements is -45.59 mil USD. Dividing these 2 quantities gives us the above VBIV EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.5x - 13.9x | 13.6x |
| Forward P/E multiples | 18.9x - 29.2x | 23.8x |
| Fair Price | (5,615.06) - (4,144.30) | (5,567.42) |
| Upside | -8598959.8% - -6346660.4% | -8526010.9% |
| Date | EV/EBITDA |